Injective has recently been in the spotlight for various notable developments. Pineapple Financial revealed it was migrating its $10B mortgage portfolio onto Injective's blockchain, showing a growing trust in the project. The coin has also gained attention for its potential, with predictions that it could reach $40 after a $6B Real World Asset boom. Injective has launched a native Ethereum Virtual Machine, anticipated to streamline DeFi transactions with faster and cheaper solutions.
Injective has made significant progress, especially with the launch of a no-code platform developed for Web3 builders and its native EVM mainnet, offering efficient on-chain finance. Highlighting its intent for growth, Injective launched a community-wide INJ buyback program in October. Furthermore, its ETF proposal managed to enter the SEC’s public comment phase, highlighting a positive future outlook.
A collaboration has been formed between Injective and Republic, aiming to democratize investing in private firms like SpaceX. The company's token seems to be gaining momentum, with Deutsche Telekom backing Injective Crypto predicting an INJ Price Reversal. This follows its completion of a community buyback worth $32 million, showing strong project support.
In terms of other advancements, Injective tokenized SharpLink’s ETH Treasury, fueling a DeFi revolution. It also bridged Ethereum and Cosmos with its EVM, breaking down interoperable barriers. Injective Protocol's bullish breakout and an increase in its year-to-date gain after its recent price jump signify positive market sentiment.
Injective Coin News Analytics from Thu, 03 Mar 2022 03:34:04 GMT to Wed, 10 Dec 2025 12:02:36 GMT - Rating 8 - Innovation 9 - Information 10 - Rumor -2